Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dr. gustav klein gmbh & co. kg - o combinatie - picaturi orale, solutie

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dr. gustav klein gmbh & co. kg - o combinatie - picaturi orale, solutie

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dr. gustav klein gmbh & co. kg - o combinatie - picaturi orale, solutie

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dr. willmar schwabe gmbh & co. kg - ginkgo biloba - comprimate filmate - 40 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

mylan dura gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - agenți antitrombotici - clopidogrelul este indicat la adulți pentru prevenirea evenimentelor aterotrombotice la:pacienții care suferă de infarct miocardic (de la câteva zile până la mai puțin de 35 zile), accident vascular cerebral ischemic (mai vechi de 7 zile până la mai puțin de 6 luni) sau boală arterială periferică dovedită.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ladeepharma kft. - combinatii (dienogestum+etinilestradiolum) - compr. film. - 2mg/1mg - combinatii de hormoni progestogeni si estrogeni progestative si estrogeni, combinatii fixe

Uniunea Europeană - română - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Uniunea Europeană - română - EMA (European Medicines Agency)

bayer animal health gmbh - iron(iii) ion, toltrazuril - toltrazuril, combinații - porci (purcei) - pentru concurente prevenirea semnelor clinice ale coccidiozei (cum ar fi diareea) la purceii nou-născuți în ferme cu un confirmată de istorie coccidiozei cauzate de cystoisospora suis, și prevenirea deficit de fier anemie.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

baxalta innovations gmbh - factorul viii de coagulare uman/factor von willebrand - pulbere şi solvent pentru soluţie injectabilă - 1000 ui/ 750 ui

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

baxalta innovations gmbh - factorul viii de coagulare uman/factor von willebrand - pulbere şi solvent pentru soluţie injectabilă - 250 ui/ 190 ui